期刊文献+

舒芬太尼在全子宫切除术后镇痛个体化用药的临床观察 被引量:7

Clinical observation on individualized medication of sufentanil for analgesia after total hysterectomy
下载PDF
导出
摘要 目的探讨并评价舒芬太尼在全子宫切除术后镇痛的个体化用药,为临床合理用药提供依据。方法选择我院全身麻醉下择期开腹行全子宫切除术65例患者,术前接受P450 CYP3A4*1G酶基因测定,按检测结果分为2组:A组为野生型纯合子组,B组为突变型纯合子组。术后自愿接受静脉自控镇痛(PCA)治疗。患者均接受全身麻醉,术毕静注0.04μg/kg负荷量舒芬太尼,连接PCA镇痛泵。入PACU后2、4、24、48 h各时点,评估患者的VAS疼痛评分和Ramsay镇静评分。记录舒芬太尼消耗量及恶心呕吐、呼吸抑制不良反应的发生率。结果两组患者2 h和4 h舒芬太尼消耗量组间比较,差异无统计学意义(t=4.21,t=5.36,P〉0.05),但A组24 h和48 h舒芬太尼消耗量少于B组(t=11.67,t=9.86,P〈0.05)。两组各时间VAS疼痛评分和Ramsay镇静评分比较,差异均无统计学意义(F=3.38,F=3.69,P〉0.05)。两组呼吸抑制发生率比较差异无统计学意义(χ~2=0.09,P〉0.05),A组恶心、呕吐的发生率明显高于B组(χ~2=4.57,P〈0.05)。结论传统的按公斤体重给予舒芬太尼的术后镇痛配方,患者不良反应发生率高。只有个体化应用,才能既充分保证完善的术后镇痛,又可减少由于镇痛药物过量带来的风险。 Objective To explore and evaluate individualized medication of sufentanil for analgesia after total hysterectomy,and guide the clinical rational drug use.Methods Sixty five patients undergoing total hysterectomy and general anesthesia were chosen,P450 enzyme gene CYP3A4* 1G was measured before operation.The patients were divided into two groups according to the test results:group A for the wild type homozygote and group B for the mutant type homozygote.0.04 μg/kg of sufentanil was given intravenously and PCA was used at the end of operation.VAS scores and agitation scores were assessed.The sufentanil consumption,the incidence of adverse reactions were recorded at 2,4,24 and 48 h in PACU.Results There was no significant difference between the two groups in consumption of sufentanil at 2 h and 4 h,but consumption of sufentanil in group A at 24 h and 48 h was less than that of group B(t =11.67,t =9.86,P〈0.05).There was no significant difference in VAS scores and Ramsay scores at every time point between the two groups(F=3.38,F=3.69,P〈0.05).The incidence of nausea and vomiting in group A were significantly higher than that in group B(χ~2=4.57,P〈0.05),while no significant difference was found in the incidence of respiratory depression between the two groups(χ~2 =0.09,P〈0.05).Conclusion The traditional postoperative analgesia in patients with sufentanil according to weight(kg) could result in high adverse reaction rate,only individualized use of sufentanil can fully guarantee the perfect postoperative analgesia,and reduce the risks of drug overdose.
出处 《实用药物与临床》 CAS 2016年第1期45-47,共3页 Practical Pharmacy and Clinical Remedies
关键词 舒芬太尼 术后镇痛 个体化 Sufentanil Postoperative analgesia Individualized
  • 相关文献

参考文献14

  • 1Hamilton M, Wolf JL, Drolet DW, et al. The effect of rifamp- iein, a prototypical CYP3A4 inducer, on erlotinib pharmaeoki- netics in healthy subjects[ J]. Cancer Chemother Pharmacol, 2014,73 (3) :613-621.
  • 2Li CJ, Li L, Lin L, et al. Impact of the CYP3AS, CYP3A4, COMT,IL-10 and POR genetic polymorphisms on tacrolimus metabolism in Chinese renal transplant recipients [ J ]. PLoS One ,2014,9 ( 1 ) : e86206.
  • 3Kurzawski M, Dabrowska J, Dziewanowski K, et al. CYP3A5 and CYP3A4, but not ABCB 1 polymorphisms affect tacrolimus dose-adjusted trough concentrations in kidney transplant recipi- ents [ J]. Pharmacogenomics ,2014,15 (2) : 179-188.
  • 4Kohlrausch FB, Carracedo A, Hutz MH. Characterization of CYP1A2, CYP2C19, CYP3A4 and CYP3A5 polymorphisms in South Brazilians[ J]. Mol Biol Rep ,2014,41 (3) : 1453-1460.
  • 5Choi JS, Choi I, Choi DH. Effects of nifedipine on the pharma- cokinetics of repaglinide in rats:possible role of CYtr3A4 and P-glycoprotein inhibition by nifedipine [ J ]. Pharmacol Rep, 2013,65 (5) : 1422-1430.
  • 6Liu G. A response to the letter of Iba on Liu et al. Effects of Panax notoginseng saponins on the activities of CYP1A2, CYP2C9, CYP2136 and CYP3A4 in rats in vivo[ J]. Phytother Res,2014,28 ( 1 ) : 152-153.
  • 7Okubo M, Murayama N, Shimizu M, et al. The CYP3 A4 intron 6 C > T polymorphism ( CYP3A4 22 ) is associated with re- duced CYP3A4 protein level and function in human liver mi- crosomes[ J]. J Toxicol Sci ,2013,38 ( 3 ) :349-354.
  • 8Rhudy JL,Bartley EJ,Wiliams AE,et al. Are there sex differ- ences in affective modulation of spinal nociception and pain [J]. J Pain,2010,11 (12) :1429-1441.
  • 9Saari TI, Lalne K, Neuvonen M, et al. Effect of vorieonazole and flu-conazole on the pharmaeokinetics of intravenous fenta- nyl[ J]. Eur J Clin Pharmacol,2008,64( 1 ) :25-30.
  • 10张卫,张豪勇,阚全程,张莉蓉,常琰子,李治松,王中玉,李岩,储勤军.CYP3A4*1G基因多态性对女性健康志愿者芬太尼药效学的影响[J].中华麻醉学杂志,2012,32(1):67-69. 被引量:7

二级参考文献8

  • 1王安,周宏灏.细胞色素氧化酶CYP3A4基因突变与表型研究进展[J].中国临床药理学杂志,2005,21(6):459-462. 被引量:11
  • 2Nagashima M, Katoh R, Sato Y, et al. Is there genetic polymor- phism evidence for individual human sensitivity to opiates? Curt Pain Headache Rep, 2007, 11(2) : 115-123.
  • 3Nielsen PR, Ncrgaard L, Rasmussen LS, et al. Prediction of post- operative pain by an electrical pain stimulus. Acta AnaesthesiolStand, 2007, 51(5): 582-586.
  • 4Schafer E, Finkensiep H, Kaup M. Effect of transcutaneous electri- cal nerve stimula-tion on pain perception threshold of human teeth : a double-blind, placebo-controlled study . Clin Oral Investig, 2000, 4 (2) : 81-86.
  • 5Lund I, Lundeberg T, Kowalski J, et al . Evaluation of variations in sensory and pain threshold assessments by electrocutaneous stimula- tion. Physiother Theory Pract, 2005, 21 (2): 81-92.
  • 6Rhudy JL, Bartley EJ, Williams AE, et al. Are there sex differences in affective modulation of spinal nociception and pain'?. J Pain, 2010, 11 (12) : 1429-1441.
  • 7Saari TI, Laine K, Neuvonen M, et al. Effect of voriconazole and fluconazole on the pharmacokinetics of intravenous fentanyl. Eur J Clin Pharmacol, 2008, 64( 1 ) :25-30.
  • 8徐凯智,胡小琴.心内直视手术中大剂量芬太尼的药代动力学研究[J].中国循环杂志,1998,13(1):32-34. 被引量:8

共引文献6

同被引文献72

引证文献7

二级引证文献23

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部